Using AWS RDS and S3 to store data about my dogs' vaccination and medical records. Creating an R shiny app to keep track of and share records with vets. 🐶 🐶

Data and code to support Barnard et al., Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era, Nature Communications (2022).

[Under active development] - A library of published compartmental epidemic models, and classes to represent demographic structure, non-pharmaceutical interventions, and vaccination regimes, to compose epidemic scenarios.

🌍 This repository hosts an in-depth analysis of COVID-19's impact across five key countries from Jan 2020 to Dec 2021. Through advanced data analysis and visualization, we aim to provide insights into how the pandemic evolved differently across these nations, shedding light on the effectiveness of various health measures and vaccination campaigns.

Code for vacccprogress Twitter bot. Tweets daily COVID-19 Vaccination progress. Data taken from Our World In Data. .

corona virus data from Polish government and more

Dynamic optimization of COVID-19 vaccine prioritization

The COVID-19 Vaccination Analysis Pipeline (CVAP) is a modular analytical pipeline designed to consolidate, analyze, and disseminate COVID-19 vaccine implementation data across all countries, areas, and territories for use by the global community.

The pebble game: A simple game that can be used to understand epidemics and vaccination

Covid-19 vaccination in Brazil analysis

Covid-19 vaccination rates in Poland by counties. The goal of the project is to provide insight into what drives vaccination rates on COVID-19 across Poland

Official Canada Vital (Deaths) Statistics, analyzed using Data Science

England and London COVID-19 data visualisation: vaccine rollout, cases, hospitalisations and deaths (daily update)

Mapping the percents of NYC residents who received at least one dose of COVID-19 vaccine; 3 levels of coverage mapped using ggplot2

Code used to produce results and figures for BA Pathology project on the prospects of a BCG vaccine program in Great Britain. Developed by Joanna Vieira O'Neill, University of Cambridge.